ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko04621	NOD-like receptor signaling pathway	7/58	157/7206	0.000241162052069
ko05321	Inflammatory bowel disease (IBD)	3/58	56/7206	0.010143037544
ko05164	Influenza A	5/58	167/7206	0.0107224077604
ko04217	Necroptosis	5/58	178/7206	0.0138506954421
ko04668	TNF signaling pathway	4/58	120/7206	0.0155457835877
ko05152	Tuberculosis	5/58	187/7206	0.0168304460538
ko04660	T cell receptor signaling pathway	4/58	124/7206	0.017339566453
ko05145	Toxoplasmosis	4/58	126/7206	0.0182831691798
ko00310	Lysine degradation	3/58	73/7206	0.0206774642196
ko05140	Leishmaniasis	3/58	75/7206	0.0221980940411
ko04380	Osteoclast differentiation	4/58	134/7206	0.0223757626449
ko05340	Primary immunodeficiency	2/58	30/7206	0.0239749180074
ko05133	Pertussis	3/58	87/7206	0.0325763457879
ko04662	B cell receptor signaling pathway	3/58	88/7206	0.0335378546056
ko05323	Rheumatoid arthritis	3/58	89/7206	0.0345141218424
ko05120	Epithelial cell signaling in Helicobacter pylori infection	3/58	92/7206	0.0375311271851
ko04145	Phagosome	4/58	162/7206	0.0408755543857
ko04064	NF-kappa B signaling pathway	3/58	96/7206	0.0417581203604
ko00051	Fructose and mannose metabolism	2/58	42/7206	0.0446380522667
ko00564	Glycerophospholipid metabolism	3/58	99/7206	0.0450799983244
ko05161	Hepatitis B	4/58	173/7206	0.0499695315297